Neuroscience Business posts are press releases issued by businesses and companies related to neuroscience research. Many of these statements contain forward looking statements and should be considered to have been written with a persuasive purpose.
Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule stabilizing agent, for the treatment of Alzheimer’s disease, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). Read More
Today the Governor’s Office of Business and Economic Development (GO-Biz) announced the formation of a new Cyber-Health Information Technology Advisory Board as part of an ongoing effort to support cybersecurity innovation and bolster advanced technology industries. Read More
On Oct. 2 at 10 a.m. Pacific (1 p.m. Eastern), Scientific Learning Corp. will present a free, online seminar by Norman Doidge, M.D., author of the New York Times and international bestseller, "The Brain That Changes Itself." Read More
Researchers reveal how two classes of drug compounds, which are currently in trial, work to fight Alzheimer's disease. They also identify possible causes of early onset hereditary forms of AD. Read More